Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial): Real-World Evidence
-
Published:2023-04
Issue:
Volume:Volume 17
Page:1067-1076
-
ISSN:1177-5483
-
Container-title:Clinical Ophthalmology
-
language:en
-
Short-container-title:OPTH
Author:
Chakraborty DebdulalORCID,
Mondal Soumen,
Boral Subhendu,
Das Arnab,
Sinha Tushar Kanti,
Majumdar Saptorshi,
Bhattacharya Ranabir,
Maitra RitobrotoORCID
Publisher
Informa UK Limited
Reference43 articles.
1. Neovascular Age-Related Macular Degeneration
2. Age-Related Macular Degeneration
3. The prevalence of age-related maculopathy by geographic region and ethnicity1This paper has been edited by Neville N. Osborne, PhD, DSc, Nuffield Laboratory of Ophthalmology, University of Oxford, Walton Street, Oxford, UK; and Gerald J. Chader, The Foundation Fighting Blindness, Hunt Valley, MS.1
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献